Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.

<h4>Background</h4> <p>Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however,>30% of patients relapse within 5 years. Clinicopathological parameters currently fail to identify patients prone to systemic relapse and those...

Full description

Bibliographic Details
Main Authors:	Jain, S, Lyons, C, Walker, S, McQuaid, S, Hynes, S, Mitchell, D, Pang, B, Logan, G, McCavigan, A, O'Rourke, D, McArt, D, McDade, S, Mills, I, Prise, K, Knight, L, Steele, C, Medlow, P, Berge, V, Katz, B, Loblaw, D, Harkin, D, James, J, O'Sullivan, J, Kennedy, R, Waugh, D
Format:	Journal article
Language:	English
Published:	Oxford University Press 2017

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy.

Similar Items